Skip to main content

Table 11 Cardiac findings focusing on structural CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD LGE-negative LGE-positive p value
N = 63 N = 15 N = 48
LV-EDVi, ml/m2 85 ± 30 72 ± 18 89 ± 32 0.06
LV-ESVi, ml/m2 41 ± 21 25 ± 7 46 ± 22 <0.0001
LV-mass, g/m2 60 ± 16 51 ± 11 62 ± 17 0.018
LV-EF, % 53 ± 12 66 ± 6 50 ± 11 <0.0001
RV-EF, % 53 ± 9 56 ± 10 52 ± 9 0.15
LV-EF <55 %, n (%) 29 (46) 1 (7) 28 (58) 0.001
RV-EF <45 %, n (%) 10 (16) 1 (7) 9 (19) 0.43
LGE extent, % 7 (1–17) - 10 (5–24) NA
Abnormal CMR, n (%) 49 (78) 1 (7) 48 (100) NA
  1. Bold text indicates a significant p-value of <0.05